Philip Morris Intl. expands into cannabis via Avicanna partnership, focusing on medical research and innovation: How this ...
Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...
Tobacco stocks gained slightly on Thursday after the FDA has authorized the marketing of 20 Zyn nicotine pouch products ...
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International's Zyn ...
Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned ...
Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...
Philip Morris International Inc. closed $16.60 below its 52-week high ($134.15), which the company reached on October 31st.
Learn how Philip Morris International plans to shift to smoke-free products by 2030 to mitigate risks, boost profits, and ...
Zeller credited Gottlieb for advocating for the nicotine regulation within the Trump White House, after the Obama ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products ...